Researchers at the National Institutes of Health (NIH) have developed a unique, improved viral vector to use in gene therapy for sickle cell disease. Using animal models, the new vector was shown to ...

A novel and improved viral vector for use in gene therapy in sickle cell disease has been developed by National Institutes of Health (NIH) researchers. In advanced lab tests using animal models, the ...

Researchers used advanced animal model lab tests to determine the new vector is 10 times more efficient at incorporating corrective genes into bone marrow stem cells than traditional vectors. The ...

Researchers at the National Institutes of Health have developed a new and improved viral vector a virus-based vehicle that delivers therapeutic genes for use in gene therapy for sickle cell disease.

Researchers have developed a new and improved viral vector -- a virus-based vehicle that delivers therapeutic genes -- for use in gene therapy for sickle cell disease. In advanced lab tests using ...